Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ASPIRIN\CLOPIDOGREL for Stent placement: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 19 adverse event reports in the FDA FAERS database where ASPIRIN\CLOPIDOGREL was used for Stent placement.

Most Reported Side Effects for ASPIRIN\CLOPIDOGREL

Side Effect Reports % Deaths Hosp.
Acute kidney injury 55 12.7% 27 32
Anaemia 47 10.9% 11 25
Vomiting 41 9.5% 10 29
Lactic acidosis 39 9.0% 32 7
Decreased appetite 32 7.4% 0 26
Nausea 32 7.4% 1 24
Off label use 31 7.2% 3 27
Abdominal pain upper 30 6.9% 4 29
Weight decreased 27 6.3% 0 26
Dizziness 26 6.0% 0 25
Ear infection 26 6.0% 0 25
Melaena 26 6.0% 0 23
Abdominal discomfort 25 5.8% 0 24
Headache 25 5.8% 0 24
Pharyngitis 25 5.8% 0 24

Other Indications for ASPIRIN\CLOPIDOGREL

Product used for unknown indication (80) Thrombosis prophylaxis (48) Myocardial ischaemia (34) Myocardial infarction (24) Prophylaxis (24) Rheumatoid arthritis (23) Acute coronary syndrome (22) Cardiovascular event prophylaxis (20) Transient ischaemic attack (19) Atherosclerosis prophylaxis (14)

Other Drugs Used for Stent placement

TICAGRELOR (3,424) CLOPIDOGREL BISULFATE (1,909) PRASUGREL (1,414) ASPIRIN (407) RIVAROXABAN (158) EVOLOCUMAB (86) METOPROLOL (80) BRILINTA (79) APIXABAN (73) PLAVIX (68)

Related Pages

ASPIRIN\CLOPIDOGREL Full Profile All Stent placement Drugs ASPIRIN\CLOPIDOGREL Demographics ASPIRIN\CLOPIDOGREL Timeline